Rajeev Saggar
Vermögen: 11 Mio $ am 31.05.2026
Vermögen: 11 Mio $ am 31.05.2026
Rajeev Saggar is currently Chief Medical Officer at Liquidia Corp.
since 2022.
Former positions include Vice President-Clinical Development at Theravance Biopharma Us LLC from 2021 to 2022, and Medical Director-Pulmonary Hypertension & Fibrosis at The Banner-University Medical Center.
Education includes a doctorate from the University of California, Irvine.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LIQUIDIA CORPORATION 0.19% | 13.04.2026 | 173’270 ( 0.19% ) | 11 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| LIQUIDIA CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 18.07.2022 |
| Unternehmen | Position | Ende |
|---|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2022 |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
University of California, Irvine
University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Banner-University Medical Center
The Banner-University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in research and development for the treatment in lungs, gastrointestinal tract and infectious diseases | Commercial Services |
Liquidia Corp.
Liquidia Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen